Literature DB >> 8897009

Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects.

D Worm1, J Vinten, P Staehr, J E Henriksen, A Handberg, H Beck-Nielsen.   

Abstract

To measure possible changes in basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from insulin-resistant individuals, soluble and particulate muscle fractions were prepared from biopsies taken before and after a 3-h hyperinsulinaemic euglycaemic clamp in eight non-insulin-dependent diabetic (NIDDM) patients and nine control subjects. We used a sensitive sandwich-immunofluorescence assay and the human insulin receptor as the substrate. PTPase activity was expressed as percentage of dephosphorylation of phosphotyrosyl-residues in immobilized insulin receptors per 2 h incubation time per 83 micrograms and 19 micrograms muscle fraction protein (soluble and particulate fraction, respectively). In the diabetic soluble muscle fractions, the basal PTPase activity was decreased compared with that of control subjects (11.5 +/- 5.5 vs 27.5 +/- 3.3, p < 0.04, mean +/- SEM). In the particulate muscle fractions from the control subjects, PTPase activity was increased after 3 h hyperinsulinaemia (20.0 +/- 3.2 vs 30.2 +/- 3.6, p < 0.03) and in the corresponding soluble fractions PTPase activity seemed decreased (27.5 +/- 3.3 vs 19.9 +/- 5.9, NS). No effect of insulin on PTPase activity was found in NIDDM patients (25.1 +/- 4.1 vs 27.2 +/- 5.2, 11.5 +/- 5.5 vs 15.1 +/- 4.5 [particulate and soluble fractions], NS). In conclusion, we found that the basal PTPase activity in soluble muscle fractions was decreased in NIDDM patients; furthermore, insulin stimulation was unable to increase PTPase activities in the particulate fractions, as opposed to the effect of insulin in control subjects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897009     DOI: 10.1007/bf02658508

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  32 in total

Review 1.  Protein-tyrosine phosphatases and the regulation of insulin action.

Authors:  B J Goldstein
Journal:  J Cell Biochem       Date:  1992-01       Impact factor: 4.429

2.  Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation.

Authors:  W Vogel; R Lammers; J Huang; A Ullrich
Journal:  Science       Date:  1993-03-12       Impact factor: 47.728

3.  Differential activities of protein tyrosine phosphatases in intact cells.

Authors:  R Lammers; B Bossenmaier; D E Cool; N K Tonks; J Schlessinger; E H Fischer; A Ullrich
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

Review 4.  Diabetes mellitus. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1985

5.  Selective down-regulation of the insulin receptor signal by protein-tyrosine phosphatases alpha and epsilon.

Authors:  N P Møller; K B Møller; R Lammers; A Kharitonenkov; E Hoppe; F C Wiberg; I Sures; A Ullrich
Journal:  J Biol Chem       Date:  1995-09-29       Impact factor: 5.157

6.  Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.

Authors:  C K Chou; T J Dull; D S Russell; R Gherzi; D Lebwohl; A Ullrich; O M Rosen
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

7.  Evidence against dephosphorylation of insulin-elicited phosphotyrosine proteins in vivo by the phosphatase PTP2C.

Authors:  M R Kuhné; Z Zhao; G E Lienhard
Journal:  Biochem Biophys Res Commun       Date:  1995-06-06       Impact factor: 3.575

8.  Insulin receptor signaling is augmented by antisense inhibition of the protein tyrosine phosphatase LAR.

Authors:  D T Kulas; W R Zhang; B J Goldstein; R W Furlanetto; R A Mooney
Journal:  J Biol Chem       Date:  1995-02-10       Impact factor: 5.157

9.  Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects.

Authors:  F Ahmad; R V Considine; B J Goldstein
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.

Authors:  O G Kolterman; R S Gray; J Griffin; P Burstein; J Insel; J A Scarlett; J M Olefsky
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

View more
  7 in total

1.  An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-A(y) mice.

Authors:  Zhong Q Wang; David Ribnicky; Xian H Zhang; Aamir Zuberi; Ilya Raskin; Yongmei Yu; William T Cefalu
Journal:  J Nutr Biochem       Date:  2010-05-05       Impact factor: 6.048

Review 2.  Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction.

Authors:  J C Byon; A B Kusari; J Kusari
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

3.  Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.

Authors:  F Ahmad; J L Azevedo; R Cortright; G L Dohm; B J Goldstein
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

4.  Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice.

Authors:  L D Klaman; O Boss; O D Peroni; J K Kim; J L Martino; J M Zabolotny; N Moghal; M Lubkin; Y B Kim; A H Sharpe; A Stricker-Krongrad; G I Shulman; B G Neel; B B Kahn
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

5.  Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.

Authors:  K Cusi; K Maezono; A Osman; M Pendergrass; M E Patti; T Pratipanawatr; R A DeFronzo; C R Kahn; L J Mandarino
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

Review 6.  Current views on type 2 diabetes.

Authors:  Yi Lin; Zhongjie Sun
Journal:  J Endocrinol       Date:  2009-09-21       Impact factor: 4.286

7.  Skeletal muscle protein tyrosine phosphatase 1B regulates insulin sensitivity in African Americans.

Authors:  April J Stull; Zhong Q Wang; Xian H Zhang; Yongmei Yu; William D Johnson; William T Cefalu
Journal:  Diabetes       Date:  2012-04-03       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.